triumph trial retatrutide 🚨 HOT OFF THE PRESS: Phase 3 data has arrived — and the obesity medicine world is paying attention. In Lilly's TRIUMPH-1 trial, participants receiving the highest dose achieved an average Looking forward to when #retatrutide's

More than 9000 patients were included with follow up of 3.8 years

The prospects of Jerusalem artichoke in functional food ingredients and bioenergy production

Show visual signs of degradation: Color changes, the appearance of particulates, or a foul odor are signs that your semaglutide has degraded

Repeated injection at the same site can cause lipohypertrophy (small fatty lumps under the skin) that affect peptide absorption

The abdomen is generally the most accessible site for self-injection

These results are a reassuring signal for clinicians and patients alike, especially as GLP-1 RAs become central in managing T2DM and obesity